Residual Adrenal Function in Addison's Disease
NCT06309498 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-03-13
Summary
The main aim of this study is to assess the role of 11-deoxycortisol as surrogate marker of Residual adrenal function.
11-deoxycortisol levels will be assessed in all recruited patients
Conditions
Interventions
- PROCEDURE
-
blood test
11 DOC levels will be measured in enrolled patients
Sponsors & Collaborators
-
Istituto Auxologico Italiano
lead OTHER
Principal Investigators
-
Valentina Morelli, PHD · Istituto Auxologico Italiano
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2024-10-30
- Completion
- 2024-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Value of 25 mcg Cortrosyn Stimulation Test
NCT01428336 ·Status: COMPLETED ·Phase: NA
-
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
NCT05302726 ·Status: UNKNOWN ·Phase: NA
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
NCT00004313 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
NCT01294319 ·Status: COMPLETED ·Phase: PHASE2
-
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
NCT06616142 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency
NCT00575341 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism
NCT00220298 ·Status: COMPLETED ·Phase: PHASE3
-
DHEA Replacement in Adrenalectomized/Hypoadrenal Patients
NCT00279929 ·Status: COMPLETED ·Phase: NA
-
Administration of Hydrocortisone in Young Healthy Male Volunteers
NCT04137302 ·Status: COMPLETED ·Phase: PHASE4
-
The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.
NCT02529306 ·Status: UNKNOWN
-
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
NCT03973840 ·Status: COMPLETED ·Phase: PHASE1
-
Dynamic Hormone Diagnostics in Endocrine Disease
NCT02934399 ·Status: COMPLETED
-
Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids
NCT02872584 ·Status: UNKNOWN
-
Leuprolide in Determining the Cause of Gonadotropin Deficiency
NCT00004426 ·Status: COMPLETED ·Phase: NA
-
Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency
NCT06754423 ·Status: RECRUITING
-
Revival of Stem Cells in Addison's Study
NCT01371526 ·Status: COMPLETED ·Phase: PHASE4
-
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
NCT03484260 ·Status: COMPLETED
-
Six Months DHEA Treatment in Female Adrenal Failure
NCT00471900 ·Status: COMPLETED ·Phase: NA
-
Testosterone MD-Lotion Residual Washing Study
NCT00996151 ·Status: COMPLETED ·Phase: PHASE1
-
The Clinical Significance of Biochemical 11 Deoxycortisol Levels
NCT04414085 ·Status: COMPLETED
-
Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
NCT00452322 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure
NCT00512408 ·Status: TERMINATED
-
Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly
NCT00111930 ·Status: COMPLETED ·Phase: NA
-
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
NCT00413244 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study of ARD-0403 in Testosterone Deficient Men
NCT00448955 ·Status: COMPLETED ·Phase: PHASE3